Compare iShares iBoxx $ High Yield Corporate Bond ETF (HYG) vs Tempus AI (TEM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
iShares iBoxx $ High Yield Corporate Bond ETF vs Tempus AI — how do they compare? iShares iBoxx $ High Yield Corporate Bond ETF trades at $77.22 (market cap $18.25B), while Tempus AI trades at $69.95 (market cap $12.77B). The key difference: iShares iBoxx $ High Yield Corporate Bond ETF is the larger of the two by market cap, and Tempus AI is trading nearer its 52-week high, iShares iBoxx $ High Yield Corporate Bond ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold iShares iBoxx $ High Yield Corporate Bond ETF for 59 Days and Tempus AI for 22 Days on average.
| HYG | TEM | |
|---|---|---|
Market Cap | $18.25B | $12.77B |
Volume | 59,233,080 | 8,980,490 |
Sector | Fixed Income | Broad Market / Factor |
52-Week High | $81.28 | $99.28 |
52-Week Low | $76.90 | $41.55 |
Typical Hold Time | 59 Days | 22 Days |
Enterprise Value | — | $13.40B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
HYG trades at $77.18, down 0.12% with a bearish technical signal from moving averages. The ETF shows neutral oscillators but faces pressure from rising Treasury yields, with the 10-year hitting 2007 highs. Recent dividend payments of $0.34-$0.44 provide income support, but bond market volatility remains a headwind as high-yield corporate debt costs increase.
Outlook remains cautious given the bearish technical setup and rising rate environment. Income investors may find value in HYG's dividend yield, but further bond market selloffs could pressure prices. Key risks include Fed policy uncertainty and corporate credit quality deterioration in a higher rate environment.
Tempus AI (TEM) trades at $70.29, down 2.35% on the day, with a bullish technical signal despite negative profitability. Recent FDA clearance for its ECG-MR AI product and 13 abstracts accepted for ESMO Congress 2026 highlight ongoing innovation. Revenue grew to $1.4B in 2026, though net losses persist. The stock shows strong analyst support with a $72.60 consensus target and 64% buy ratings.
Outlook remains cautiously optimistic driven by AI healthcare adoption and data licensing growth, but high valuation multiples and sustained losses pose risks. Investor sentiment is positive amid recent insider selling and institutional interest, yet profitability challenges and competitive pressures require monitoring for long-term value creation.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About iShares iBoxx $ High Yield Corporate Bond ETF
HYG is the world's largest high-yield bond ETF, tracking the Markit iBoxx USD Liquid High Yield Index. It provides liquid exposure to non-investment grade corporate debt, with 2026 top holdings including Cloud Software Group and Medline.
Read more on HYG →About Tempus AI
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
Read more on TEM →
